{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:47:26Z","timestamp":1790736446765,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejca.2023.113350","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:07:27Z","timestamp":1695694047000},"page":"113350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["European trends in ovarian cancer mortality, 1990\u20132020 and predictions to 2025"],"prefix":"10.1016","volume":"194","author":[{"given":"Cezary","family":"Wojty\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bertuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Giermaziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-5307","authenticated-orcid":false,"given":"Claudia","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Odone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Ciebiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-8526","authenticated-orcid":false,"given":"Eva","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wojty\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2023.113350_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.annonc.2021.12.007","article-title":"European cancer mortality predictions for the year 2022 with focus on ovarian cancer","volume":"33","author":"Dalmartello","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113350_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.01.007","article-title":"Persisting cancer mortality gap between Western and Eastern Europe","volume":"165","author":"Santucci","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113350_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejca.2021.04.026","article-title":"European trends in breast cancer mortality, 1980-2017 and predictions to 2025","volume":"152","author":"Wojtyla","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113350_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2019.11.018","article-title":"Cervical cancer mortality in young adult European women","volume":"126","author":"Wojtyla","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113350_bib5","unstructured":"World Health Organization Statistical Information System. WHO mortality database; \u3008https:\/\/www.who.int\/data\/data-collection-tools\/who-mortality-database\u3009. [Accessed on 20th October 2022]."},{"key":"10.1016\/j.ejca.2023.113350_bib6","series-title":"International classification of disease","author":"World Health Organization","year":"1967"},{"key":"10.1016\/j.ejca.2023.113350_bib7","series-title":"International classification of disease","author":"World Health Organization","year":"1977"},{"key":"10.1016\/j.ejca.2023.113350_bib8","series-title":"International classification of disease and related health problems","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.ejca.2023.113350_bib9","unstructured":"European Commission. Eurostat population database; \u3008http:\/\/epp.eurostat.ec.europa.eu\/portal\/page\/portal\/population\/data\/database\u3009. [Accessed on 20th October 2022]."},{"key":"10.1016\/j.ejca.2023.113350_bib10","unstructured":"Esteve J, Benhamou E, Raymond L. Techniques for the analysis of cancer risk. In: Statistical methods in cancer research. Volume IV. Descriptive epidemiology. Oxford: Oxford University Press; 1994."},{"key":"10.1016\/j.ejca.2023.113350_bib11","unstructured":"National Cancer Institute . Joinpoint regression program, version 4.9.0.0."},{"key":"10.1016\/j.ejca.2023.113350_bib12","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2023.113350_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"37","key":"10.1016\/j.ejca.2023.113350_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/EDBK_180330","article-title":"European\/U.S. Comparison and contrasts in ovarian cancer screening and prevention in a high-risk population","author":"Mourits","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10.1016\/j.ejca.2023.113350_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113350_bib16","unstructured":"International Agency for Research on Cancer. Globocan; 2020. Available at: \u3008https:\/\/gco.iarc.fr\/\u3009. [Accessed on 1st July 2023]."},{"key":"10.1016\/j.ejca.2023.113350_bib17","first-page":"1","article-title":"Oral contraceptive use for the primary prevention of ovarian cancer","volume":"212","author":"Havrilesky","year":"2013","journal-title":"Evid Rep Technol Assess"},{"issue":"1","key":"10.1016\/j.ejca.2023.113350_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2023.113350_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejca.2023.113350_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10680-016-9378-0","article-title":"Ready, willing, and able: contraceptive use patterns across europe","volume":"32","author":"Dereuddre","year":"2016","journal-title":"Eur J Popul"},{"key":"10.1016\/j.ejca.2023.113350_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estro-gen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"9382","key":"10.1016\/j.ejca.2023.113350_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2023.113350_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.maturitas.2014.07.002","article-title":"Menopausal hormone therapy use in 17 European countries during the last decade","volume":"79","author":"Ameye","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.ejca.2023.113350_bib24","unstructured":"Eurostat. Fertility statistics. \u3008https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Fertility_statistics\u3009. [Acessed 19th June 2023]."},{"issue":"1","key":"10.1016\/j.ejca.2023.113350_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CEJ.0b013e328354d2d7","article-title":"Cancer prevention in Europe: the Mediterranean diet as a protective choice","volume":"22","author":"Giacosa","year":"2013","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"10.1016\/j.ejca.2023.113350_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.1422","article-title":"Diet and ovarian cancer risk: a case-control study in Italy","volume":"93","author":"Bosetti","year":"2001","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2023.113350_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2014.08.002","article-title":"Epigenetic epidemiology of cancer","volume":"455","author":"Barrow","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.ejca.2023.113350_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2053369117709225","article-title":"Obesity and ovarian cancer risk: a systematic review","volume":"23","author":"Foong","year":"2017","journal-title":"Post Reprod Health"},{"issue":"10113","key":"10.1016\/j.ejca.2023.113350_bib29","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejca.2023.113350_bib30","doi-asserted-by":"crossref","first-page":"679e89","DOI":"10.1007\/s00394-014-0746-4","article-title":"Overweight and obesity in 16 European countries","volume":"54","author":"Gallus","year":"2015","journal-title":"Eur J Nutr"},{"issue":"6","key":"10.1016\/j.ejca.2023.113350_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/annonc\/mdt333","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Ann Oncol"},{"issue":"Suppl.8","key":"10.1016\/j.ejca.2023.113350_bib32","doi-asserted-by":"crossref","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","article-title":"Real-world evidence in the treatment of ovarian cancer","volume":"28","author":"Eisenhauer","year":"2017","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2023.113350_bib33","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/cncr.32004","article-title":"Critical questions in ovarian cancer research and treatment: report of an American Association for Cancer Research Special Conference","volume":"125","author":"Bast","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113350_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/cancers13030446","article-title":"A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin","volume":"13","author":"Fan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2023.113350_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s10654-023-01044-x","article-title":"A comprehensive analysis of all cause and cause specific excess deaths in 30 countries during 2020","author":"Alicandro","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ejca.2023.113350_bib36","series-title":"Cancer services disruptions during the war in Ukraine. Results from a joint multidisciplinary survey","author":"Charalambous","year":"2022"},{"issue":"1","key":"10.1016\/j.ejca.2023.113350_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ijgc-2018-000016","article-title":"Ovarian cancer: screening and future directions","volume":"29","author":"Gupta","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2023.113350_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2023.113350_bib39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejca.2023.113350_bib40","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/ijc.34002","article-title":"Ovarian cancer today and tomorrow: a global assessment by world region and Human Development Index using GLOBOCAN 2020","volume":"151","author":"Cabasag","year":"2022","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923006524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923006524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:40:36Z","timestamp":1716392436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923006524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"alternative-id":["S0959804923006524"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113350","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European trends in ovarian cancer mortality, 1990\u20132020 and predictions to 2025","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113350"}}